{"id":46419,"date":"2022-07-21T12:01:54","date_gmt":"2022-07-21T10:01:54","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/in-vitro-diagnostic-market-update-q4-2021-the-major-trends-affecting-the-market-telehealth-and-remote-patient-monitoring-multiplex-and-syndromic-testing-personalized-medicine-point-of-care-r\/"},"modified":"2022-07-21T12:01:54","modified_gmt":"2022-07-21T10:01:54","slug":"in-vitro-diagnostic-market-update-q4-2021-the-major-trends-affecting-the-market-telehealth-and-remote-patient-monitoring-multiplex-and-syndromic-testing-personalized-medicine-point-of-care-r","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/in-vitro-diagnostic-market-update-q4-2021-the-major-trends-affecting-the-market-telehealth-and-remote-patient-monitoring-multiplex-and-syndromic-testing-personalized-medicine-point-of-care-r\/","title":{"rendered":"In Vitro Diagnostic Market Update, Q4, 2021: The Major Trends Affecting the Market – Telehealth and Remote Patient Monitoring, Multiplex and Syndromic Testing, Personalized Medicine, Point-of-Care – ResearchAndMarkets.com"},"content":{"rendered":"
\n

DUBLIN–(BUSINESS WIRE)–The “In Vitro Diagnostic Market Brief Update”<\/a> report has been added to ResearchAndMarkets.com’s<\/strong> offering.\n<\/p>\n

<\/a><\/p>\n

\nWhat Major Trends are Affecting the Market<\/strong>\n<\/p>\n

\nDiagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from the analysts to reflect the latest information as of Q4 2021. As part of its coverage, this report contains market sizing for several major categories of IVD.\n<\/p>\n

\nThe demand for testing and movement of current and new technologies has continued to demonstrate gains in most areas of the IVD market. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly evolving market picture\n<\/p>\n

\nThere are some growing segments in the market that have attracted industry attention. Among these are next-generation sequencing (NGS), cancer testing, and companion diagnostics technologies. Immunochemistry, point-of-care (POC) testing, and molecular diagnostics are also segments of great market interest, anticipated to be a big part of the future of IVD. The IVD market remains dynamic, demonstrating constant innovations.\n<\/p>\n

\nThe analyst has been diligent in outlining the IVD market and its rapidly changing landscape. COVID-19 has provided many positive aspects for the IVD diagnostic market but forecasting the market has become very difficult due to the uncertain progression of COVID-19. The analyst has been superior in accessing the market due to the extensive experience of its authors and commitment by the company to present the most accurate data available.\n<\/p>\n

\nKey Topics Covered:<\/strong>\n<\/p>\n

\nChapter One: Worldwide IVD Market – Q4 2021 Update<\/strong>\n<\/p>\n